Literature DB >> 23373773

Heads or tails? Choosing a salvage therapy for relapsed/refractory Hodgkin lymphoma.

Alan P Skarbnik, Barbara Pro.   

Abstract

Entities:  

Mesh:

Year:  2013        PMID: 23373773     DOI: 10.1586/ehm.12.71

Source DB:  PubMed          Journal:  Expert Rev Hematol        ISSN: 1747-4094            Impact factor:   2.929


× No keyword cloud information.
  1 in total

1.  Brentuximab vedotin for relapsed or refractory Hodgkin lymphoma: experience in Turkey.

Authors:  A Salihoglu; T Elverdi; I Karadogan; S Paydas; E Ozdemir; G Erdem; N Karadurmus; G Akyol; L Kaynar; Za Yegin; G Sucak; V Ozkocaman; P Topcuoglu; M Ozcan; E Birtas; H Goker; Z Baslar; B Ferhanoglu
Journal:  Ann Hematol       Date:  2014-09-18       Impact factor: 3.673

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.